Stock Market News·2025-10-29 09:09Market Overview - Global financial markets are influenced by a combination of economic data, corporate earnings, and geopolitical tensions, including automotive production halts and inflation metrics [2] - Ongoing property market issues in China are affecting investor sentiment, while U.S. policy initiatives aim for energy abundance and faster drug approvals [2] Automotive Sector - Honda announced a temporary production halt at its Celaya, Mexico plant due to severe supply chain issues, particularly a global semiconductor chip shortage, impacting its North American operations [3] - Mercedes-Benz reported a 31% year-on-year decline in third-quarter net income to €1.19 billion, with revenue down 7% to €32.15 billion, primarily due to weak demand in China and U.S. tariffs [4] Inflation and Monetary Policy - The U.S. core Consumer Price Index (CPI) rose by 0.23% month-over-month in September, leading to a year-over-year increase of 3.0%, driven by cooling shelter inflation and falling used car prices [5] Gold Market - Gold prices have shown significant volatility, surpassing $4,000 per ounce and reaching an all-time high of $4,381.58 in October 2025, but recently dipped below $4,000 due to easing safe-haven demand [6][7] China's Property Crisis - Fitch Ratings warns that China's property crisis will extend into 2026, with new home sales expected to decline by 15-20%, further impacting the asset quality of Chinese banks [8] Energy Policy - The U.S. Department of Energy is pursuing an "energy abundance" policy, aiming to keep energy prices down and accelerate the commercialization of fusion energy by the mid-2030s [9] Sovereign Wealth Fund Performance - Norway's Sovereign Wealth Fund reported a 5.7% return on investments for the first half of 2025, driven by strong equity market performance, particularly in the financial sector [10] Drug Approvals - The U.S. FDA is set to accelerate generic biological drug approvals, with 2025 expected to be a record year for biosimilar approvals, potentially reducing prescription drug costs significantly [11]